These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15381668)

  • 1. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent in patients with diabetes mellitus.
    Finn AV; Gold HK
    Circulation; 2004 Sep; 110(12):e318-9; author reply e318-9. PubMed ID: 15381668
    [No Abstract]   [Full Text] [Related]  

  • 2. Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial.
    Hermiller JB; Raizner A; Cannon L; Gurbel PA; Kutcher MA; Wong SC; Russell ME; Ellis SG; Mehran R; Stone GW;
    J Am Coll Cardiol; 2005 Apr; 45(8):1172-9. PubMed ID: 15837245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymer-based paclitaxel-eluting stents in percutaneous coronary intervention: a review of the TAXUS trials.
    Halkin A; Stone GW
    J Interv Cardiol; 2004 Oct; 17(5):271-82. PubMed ID: 15491330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Final 5-year results of the TAXUS II trial: a randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for de novo coronary artery lesions.
    Silber S; Colombo A; Banning AP; Hauptmann K; Drzewiecki J; Grube E; Dudek D; Baim DS
    Circulation; 2009 Oct; 120(15):1498-504. PubMed ID: 19786634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice.
    Dawkins KD; Grube E; Guagliumi G; Banning AP; Zmudka K; Colombo A; Thuesen L; Hauptman K; Marco J; Wijns W; Popma JJ; Koglin J; Russell ME;
    Circulation; 2005 Nov; 112(21):3306-13. PubMed ID: 16286586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary artery.
    Dangas G; Ellis SG; Shlofmitz R; Katz S; Fish D; Martin S; Mehran R; Russell ME; Stone GW;
    J Am Coll Cardiol; 2005 Apr; 45(8):1186-92. PubMed ID: 15837247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymer-based paclitaxel-eluting coronary stents. Clinical results in de novo lesions.
    Chieffo A; Colombo A
    Herz; 2004 Mar; 29(2):147-51. PubMed ID: 15054587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of randomized trials of drug-eluting stents versus bare metal stents in patients with diabetes mellitus.
    Boyden TF; Nallamothu BK; Moscucci M; Chan PS; Grossman PM; Tsai TT; Chetcuti SJ; Bates ER; Gurm HS
    Am J Cardiol; 2007 May; 99(10):1399-402. PubMed ID: 17493468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery disease.
    Lansky AJ; Costa RA; Mooney M; Midei MG; Lui HK; Strickland W; Mehran R; Leon MB; Russell ME; Ellis SG; Stone GW;
    J Am Coll Cardiol; 2005 Apr; 45(8):1180-5. PubMed ID: 15837246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TAXUS VI 2-year follow-up: randomized comparison of polymer-based paclitaxel-eluting with bare metal stents for treatment of long, complex lesions.
    Grube E; Dawkins KD; Guagliumi G; Banning AP; Zmudka K; Colombo A; Thuesen L; Hauptman K; Marco J; Wijns W; Popma JJ; Buellesfeld L; Koglin J; Russell ME
    Eur Heart J; 2007 Nov; 28(21):2578-82. PubMed ID: 17938126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes with the paclitaxel-eluting stent in patients with acute coronary syndromes: analysis from the TAXUS-IV trial.
    Moses JW; Mehran R; Nikolsky E; Lasala JM; Corey W; Albin G; Hirsch C; Leon MB; Russell ME; Ellis SG; Stone GW
    J Am Coll Cardiol; 2005 Apr; 45(8):1165-71. PubMed ID: 15837244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-year-plus follow-up of a paclitaxel-eluting stent in de novo coronary narrowings (TAXUS I).
    Grube E; Silber S; Hauptmann KE; Buellesfeld L; Mueller R; Lim V; Gerckens U; Russell ME
    Am J Cardiol; 2005 Jul; 96(1):79-82. PubMed ID: 15979439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug-eluting stents for diabetic patients. A critical appraisal of the currently available data from randomized trials].
    Silber S; Herdeg C
    Herz; 2008 Apr; 33(3):196-205. PubMed ID: 18568314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymer-based paclitaxel-eluting stent for treatment of chronic total occlusions of native coronaries: results of a Taxus CTO registry.
    Buellesfeld L; Gerckens U; Mueller R; Schmidt T; Grube E
    Catheter Cardiovasc Interv; 2005 Oct; 66(2):173-7. PubMed ID: 16144017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twelve-month outcomes with a paclitaxel-eluting stent transitioning from controlled trials to clinical practice (the WISDOM Registry).
    Abizaid A; Chan C; Lim YT; Kaul U; Sinha N; Patel T; Tan HC; Lopez-Cuellar J; Gaxiola E; Ramesh S; Rodriguez A; Russell ME;
    Am J Cardiol; 2006 Oct; 98(8):1028-32. PubMed ID: 17027565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel-eluting stents: current clinical experience.
    Grube E; Buellesfeld L
    Am J Cardiovasc Drugs; 2004; 4(6):355-60. PubMed ID: 15554720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: results from the TAXUS-IV Trial.
    Halkin A; Mehran R; Casey CW; Gordon P; Matthews R; Wilson BH; Leon MB; Russell ME; Ellis SG; Stone GW
    Am Heart J; 2005 Dec; 150(6):1163-70. PubMed ID: 16338253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which parameter should be chosen as primary endpoint for randomized drug-eluting stent studies?
    Silber S
    J Interv Cardiol; 2004 Dec; 17(6):375-85. PubMed ID: 15546289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: a report from the SCAAR (Swedish Angiography and Angioplasty Registry).
    Fröbert O; Lagerqvist B; Carlsson J; Lindbäck J; Stenestrand U; James SK
    J Am Coll Cardiol; 2009 May; 53(18):1660-7. PubMed ID: 19406341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-eluting stents: from randomized trials to the real world.
    Saia F; Degertekin M; Lemos PA; Serruys PW
    Minerva Cardioangiol; 2004 Oct; 52(5):349-63. PubMed ID: 15514571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.